CONTACT US

Skyepharma is a specialist CDMO

for the development and manufacturing of complex oral solid forms for controlled release applications.

  • Tab-in-tab
  • Multi-layer tablets
  • Enteric capsules

please complete this questionnaire

Fully integrated CDMO offering tailor-made solutions

We provide tailor-made solutions to our customers by positioning ourselves as a fully integrated CDMO offering a wide range of premium services.


Our experienced team of specialists works to optimize target product profile and drug development program from early formulation development, scale-up, manufacturing and packaging to regulatory support.

CDMO center of excellence in Development

Formulation development

We have extensive experience in solving complex formulation challenges. Our experts will advise you on the best solution to optimise drug delivery for the benefit to the patients. We could include our range of proprietary technologies to provide modified, pulse or timed release profiles  to solve technological challenges, to provide patient benefits and to offer additional proprietary protection to the product.

Prototyping

We perform rapid and flexible prototyping essays to early characterized powders leading to anticipate potential up scaling issues which lead to save time and money.


Our key differentiators regards our compression simulator (Styl’One Evolution) and low scale equipment which reproduce industrial processes such as wet granulation, compression including tabletting and roller compaction and coating.

Product manufacturing for clinical trial

Once formulation is validated, we use our cGMP facilities to supply product for clinical study. Regulatory support is provided to assist you during clinical phases.

Controlled release technologies

Oral Drug Delivery Technologies

Skyepharma controlled release expertise is the result of years as a leader in drug development and oral drug delivery technologies serving the global pharmaceutical industry. Since it was founded, Skyepharma has had a strong focus on oral drug delivery, solving the many challenges of delivering the right dose of a drug to the right part of the gastrointestinal system for absorption at the right time and at the appropriate rate to achieve the desired therapeutic effect.

Oral Patented Technologies

3 patented pharmaceutical technologies: Geomatrix®, Geoclock®,and Soctec®. These platforms allow us to build controlled release formulations to adapt to patient dosing schedules or adjust API intake. These proprietary technologies allow us to better manage side effects

Brand new packaging lines - Serialization & aggregation: 

Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation.  

WE ARE AVAILABLE FOR YOU

CONTACT US

Go to article: Home | The promise of billion-dollar KRAS drugsGo to article: In this issueGo to article: ContentsGo to article:  Wek-tec Company InsightGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: SHL Medical Company Insight Go to article: SHL MedicalGo to article: AgilentGo to article: CommentGo to article: The potential of virtual reality-based therapy for serious mental disordersGo to article: Brazil: an untapped market for big pharma manufacturingGo to article: More big wins for the AstraZeneca-Daiichi Sankyo collaborationGo to article: Dry powder inhalers carry potential to decrease greenhouse emissionsGo to article: Black participants severely underrepresented in global oncology studiesGo to article: Polio outbreak in New York state due to low vaccination coverageGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: SkyepharmaGo to article: In DepthGo to article: Exploring the promise of billion-dollar KRAS drugsGo to article: Nanorobots: small solutions to big delivery problemsGo to article: Foreign investments amplify the nucleic acid therapeutics fieldGo to article: Going beyond the mirage of complete skin clearance in psoriasisGo to article: As Russia’s clinical trials sector falls, Ukraine rebuildsGo to article: CMO Moves: Regulatory catalysts for drug manufacturing—SeptemberGo to article: Dr. Paul LohmannGo to article: BaxterGo to article: In DataGo to article: Top pharma companies best positioned to weather industry disruptionGo to article: Which pharma companies lead the way in artificial intelligence?Go to article: North America sees a hiring jump in big data roles in pharmaGo to article: Cloud computing mentions decrease in pharma filingsGo to article: EventsGo to article: Next issue